APO Research
Talk to an analyst

APO RESEARCH · REPORT

Long-Acting Contraceptive Pills

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Long-Acting Contraceptive Pills Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025189 pages

Choose your research edition.

Industry ResearchLong-Acting Contraceptive Pills Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Long-Acting Contraceptive Pills Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Long-Acting Contraceptive Pills Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Long-Acting Contraceptive Pills Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Long-Acting Contraceptive Pills Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Long-Acting Contraceptive Pills market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Long-Acting Contraceptive Pills is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Long-Acting Contraceptive Pills is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Long-Acting Contraceptive Pills is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Long-Acting Contraceptive Pills is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Long-Acting Contraceptive Pills include Bayer, Cipla, Merck, Sun Pharma, Teva Pharmaceuticals, Pfizer, Mylan, Shanghai Pharmaceuticals and Zhejiang Xianju Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Long-Acting Contraceptive Pills market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Long-Acting Contraceptive Pills and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Long-Acting Contraceptive Pills sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Long-Acting Contraceptive Pills market size, projected growth trends, production technologies, key applications, and end-use industries.

Long-Acting Contraceptive Pills Segment by Company

Bayer

Cipla

Merck

Sun Pharma

Teva Pharmaceuticals

Pfizer

Mylan

Shanghai Pharmaceuticals

Zhejiang Xianju Pharmaceutical

Long-Acting Contraceptive Pills Segment by Type

Injectables

Subdermal Implants

Intrauterine Devices

Other

Long-Acting Contraceptive Pills Segment by Application

Hospital

Clinic

Long-Acting Contraceptive Pills Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Long-Acting Contraceptive Pills market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Long-Acting Contraceptive Pills and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Long-Acting Contraceptive Pills.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Long-Acting Contraceptive Pills market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Long-Acting Contraceptive Pills manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Long-Acting Contraceptive Pills in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Long-Acting Contraceptive Pills in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Long-Acting Contraceptive Pills Industry Trends Table 2. Long-Acting Contraceptive Pills Industry Drivers Table 3. Long-Acting Contraceptive Pills Industry Opportunities and Challenges Table 4. Long-Acting Contraceptive Pills Industry Restraints Table 5. Global Long-Acting Contraceptive Pills Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Long-Acting Contraceptive Pills Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Long-Acting Contraceptive Pills Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Long-Acting Contraceptive Pills Sales Market Share by Manufacturers Table 9. Global Long-Acting Contraceptive Pills Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Long-Acting Contraceptive Pills Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Long-Acting Contraceptive Pills Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Long-Acting Contraceptive Pills Manufacturers, Product Type & Application Table 13. Global Long-Acting Contraceptive Pills Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Long-Acting Contraceptive Pills by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Injectables Table 17. Major Manufacturers of Subdermal Implants Table 18. Major Manufacturers of Intrauterine Devices Table 19. Major Manufacturers of Other Table 20. Global Long-Acting Contraceptive Pills Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Long-Acting Contraceptive Pills Sales by Type (2021-2026) & (K Units) Table 22. Global Long-Acting Contraceptive Pills Sales by Type (2027-2032) & (K Units) Table 23. Global Long-Acting Contraceptive Pills Sales Market Share by Type (2021-2026) Table 24. Global Long-Acting Contraceptive Pills Sales Market Share by Type (2027-2032) Table 25. Global Long-Acting Contraceptive Pills Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Long-Acting Contraceptive Pills Revenue by Type (2021-2026) & (K Units) Table 27. Global Long-Acting Contraceptive Pills Revenue by Type (2027-2032) & (K Units) Table 28. Global Long-Acting Contraceptive Pills Revenue Market Share by Type (2021-2026) Table 29. Global Long-Acting Contraceptive Pills Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Clinic Table 32. Global Long-Acting Contraceptive Pills Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Long-Acting Contraceptive Pills Sales by Application (2021-2026) & (K Units) Table 34. Global Long-Acting Contraceptive Pills Sales by Application (2027-2032) & (K Units) Table 35. Global Long-Acting Contraceptive Pills Sales Market Share by Application (2021-2026) Table 36. Global Long-Acting Contraceptive Pills Sales Market Share by Application (2027-2032) Table 37. Global Long-Acting Contraceptive Pills Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Long-Acting Contraceptive Pills Revenue by Application (2021-2026) & (K Units) Table 39. Global Long-Acting Contraceptive Pills Revenue by Application (2027-2032) & (K Units) Table 40. Global Long-Acting Contraceptive Pills Revenue Market Share by Application (2021-2026) Table 41. Global Long-Acting Contraceptive Pills Revenue Market Share by Application (2027-2032) Table 42. Global Long-Acting Contraceptive Pills Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Long-Acting Contraceptive Pills Sales by Region (2021-2026) & (K Units) Table 44. Global Long-Acting Contraceptive Pills Sales Market Share by Region (2021-2026) Table 45. Global Long-Acting Contraceptive Pills Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Long-Acting Contraceptive Pills Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Long-Acting Contraceptive Pills Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Long-Acting Contraceptive Pills Sales by Country (2021-2026) & (K Units) Table 49. North America Long-Acting Contraceptive Pills Sales by Country (2027-2032) & (K Units) Table 50. Europe Long-Acting Contraceptive Pills Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Long-Acting Contraceptive Pills Sales by Country (2021-2026) & (K Units) Table 52. Europe Long-Acting Contraceptive Pills Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Long-Acting Contraceptive Pills Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Long-Acting Contraceptive Pills Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Long-Acting Contraceptive Pills Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Long-Acting Contraceptive Pills Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Long-Acting Contraceptive Pills Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Long-Acting Contraceptive Pills Sales by Country (2027-2032) & (K Units) Table 59. Global Long-Acting Contraceptive Pills Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Long-Acting Contraceptive Pills Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Long-Acting Contraceptive Pills Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Long-Acting Contraceptive Pills Revenue Market Share by Region (2021-2026) Table 63. Global Long-Acting Contraceptive Pills Revenue Market Share by Region (2027-2032) Table 64. Bayer Company Information Table 65. Bayer Business Overview Table 66. Bayer Long-Acting Contraceptive Pills Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Bayer Long-Acting Contraceptive Pills Product Portfolio Table 68. Bayer Recent Development Table 69. Cipla Company Information Table 70. Cipla Business Overview Table 71. Cipla Long-Acting Contraceptive Pills Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Cipla Long-Acting Contraceptive Pills Product Portfolio Table 73. Cipla Recent Development Table 74. Merck Company Information Table 75. Merck Business Overview Table 76. Merck Long-Acting Contraceptive Pills Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Merck Long-Acting Contraceptive Pills Product Portfolio Table 78. Merck Recent Development Table 79. Sun Pharma Company Information Table 80. Sun Pharma Business Overview Table 81. Sun Pharma Long-Acting Contraceptive Pills Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Sun Pharma Long-Acting Contraceptive Pills Product Portfolio Table 83. Sun Pharma Recent Development Table 84. Teva Pharmaceuticals Company Information Table 85. Teva Pharmaceuticals Business Overview Table 86. Teva Pharmaceuticals Long-Acting Contraceptive Pills Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Teva Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolio Table 88. Teva Pharmaceuticals Recent Development Table 89. Pfizer Company Information Table 90. Pfizer Business Overview Table 91. Pfizer Long-Acting Contraceptive Pills Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Pfizer Long-Acting Contraceptive Pills Product Portfolio Table 93. Pfizer Recent Development Table 94. Mylan Company Information Table 95. Mylan Business Overview Table 96. Mylan Long-Acting Contraceptive Pills Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Mylan Long-Acting Contraceptive Pills Product Portfolio Table 98. Mylan Recent Development Table 99. Shanghai Pharmaceuticals Company Information Table 100. Shanghai Pharmaceuticals Business Overview Table 101. Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolio Table 103. Shanghai Pharmaceuticals Recent Development Table 104. Zhejiang Xianju Pharmaceutical Company Information Table 105. Zhejiang Xianju Pharmaceutical Business Overview Table 106. Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Product Portfolio Table 108. Zhejiang Xianju Pharmaceutical Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Long-Acting Contraceptive Pills Distributors List Table 112. Long-Acting Contraceptive Pills Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Long-Acting Contraceptive Pills Product Image Figure 2. Global Long-Acting Contraceptive Pills Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Long-Acting Contraceptive Pills Market Size (2021-2032) & (US$ Million) Figure 4. Global Long-Acting Contraceptive Pills Sales (2021-2032) & (K Units) Figure 5. Global Long-Acting Contraceptive Pills Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Long-Acting Contraceptive Pills Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Injectables Image Figure 9. Subdermal Implants Image Figure 10. Intrauterine Devices Image Figure 11. Other Image Figure 12. Global Long-Acting Contraceptive Pills Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Long-Acting Contraceptive Pills Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Long-Acting Contraceptive Pills Sales Market Share by Type (2021-2032) Figure 15. Global Long-Acting Contraceptive Pills Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Long-Acting Contraceptive Pills Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Long-Acting Contraceptive Pills Revenue Market Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Global Long-Acting Contraceptive Pills Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Long-Acting Contraceptive Pills Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Long-Acting Contraceptive Pills Sales Market Share by Application (2021-2032) Figure 23. Global Long-Acting Contraceptive Pills Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Long-Acting Contraceptive Pills Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Long-Acting Contraceptive Pills Revenue Market Share by Application (2021-2032) Figure 26. North America Long-Acting Contraceptive Pills Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Long-Acting Contraceptive Pills Sales Market Share by Country (2021-2032) Figure 28. U.S. Long-Acting Contraceptive Pills Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Long-Acting Contraceptive Pills Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Long-Acting Contraceptive Pills Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Long-Acting Contraceptive Pills Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Long-Acting Contraceptive Pills Sales Market Share by Country (2021-2032) Figure 33. Germany Long-Acting Contraceptive Pills Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Long-Acting Contraceptive Pills Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Long-Acting Contraceptive Pills Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Long-Acting Contraceptive Pills Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Long-Acting Contraceptive Pills Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Long-Acting Contraceptive Pills Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Long-Acting Contraceptive Pills Sales Market Share by Country (2021-2032) Figure 40. China Long-Acting Contraceptive Pills Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Long-Acting Contraceptive Pills Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Long-Acting Contraceptive Pills Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Long-Acting Contraceptive Pills Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Long-Acting Contraceptive Pills Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Long-Acting Contraceptive Pills Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Long-Acting Contraceptive Pills Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Long-Acting Contraceptive Pills Sales Market Share by Country (2021-2032) Figure 48. Brazil Long-Acting Contraceptive Pills Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Long-Acting Contraceptive Pills Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Long-Acting Contraceptive Pills Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Long-Acting Contraceptive Pills Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Long-Acting Contraceptive Pills Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Long-Acting Contraceptive Pills Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Long-Acting Contraceptive Pills Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Long-Acting Contraceptive Pills Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Long-Acting Contraceptive Pills Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Long-Acting Contraceptive Pills Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Figure 59. North America Long-Acting Contraceptive Pills Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Figure 61. Europe Long-Acting Contraceptive Pills Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Long-Acting Contraceptive Pills Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Long-Acting Contraceptive Pills Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Long-Acting Contraceptive Pills Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Long-Acting Contraceptive Pills Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Long-Acting Contraceptive Pills Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Injectables
  • Subdermal Implants
  • Intrauterine Devices
  • Other
Applications
  • Hospital
  • Clinic
Companies covered
  • Bayer
  • Cipla
  • Merck
  • Sun Pharma
  • Teva Pharmaceuticals
  • Pfizer
  • Mylan
  • Shanghai Pharmaceuticals
  • Zhejiang Xianju Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Long-Acting Contraceptive Pills Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Long-Acting Contraceptive Pills Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Long-Acting Contraceptive Pills Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Long-Acting Contraceptive Pills Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Long-Acting Contraceptive Pills Market Dynamics
  1. 2.1 Long-Acting Contraceptive Pills Industry Trends
  2. 2.2 Long-Acting Contraceptive Pills Industry Drivers
  3. 2.3 Long-Acting Contraceptive Pills Industry Opportunities and Challenges
  4. 2.4 Long-Acting Contraceptive Pills Industry Restraints
3 Long-Acting Contraceptive Pills Market by Manufacturers
  1. 3.1 Global Long-Acting Contraceptive Pills Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Long-Acting Contraceptive Pills Sales by Manufacturers (2021-2026)
  3. 3.3 Global Long-Acting Contraceptive Pills Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Long-Acting Contraceptive Pills Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Long-Acting Contraceptive Pills Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Long-Acting Contraceptive Pills Manufacturers, Product Type & Application
  7. 3.7 Global Long-Acting Contraceptive Pills Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Long-Acting Contraceptive Pills Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Long-Acting Contraceptive Pills Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Long-Acting Contraceptive Pills Tier 1, Tier 2, and Tier 3
4 Long-Acting Contraceptive Pills Market by Type
  1. 4.1 Long-Acting Contraceptive Pills Type Introduction
  2. 4.1.1 Injectables
  3. 4.1.2 Subdermal Implants
  4. 4.1.3 Intrauterine Devices
  5. 4.1.4 Other
  6. 4.2 Global Long-Acting Contraceptive Pills Sales by Type
  7. 4.2.1 Global Long-Acting Contraceptive Pills Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Long-Acting Contraceptive Pills Sales by Type (2021-2032)
  9. 4.2.3 Global Long-Acting Contraceptive Pills Sales Market Share by Type (2021-2032)
  10. 4.3 Global Long-Acting Contraceptive Pills Revenue by Type
  11. 4.3.1 Global Long-Acting Contraceptive Pills Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Long-Acting Contraceptive Pills Revenue by Type (2021-2032)
  13. 4.3.3 Global Long-Acting Contraceptive Pills Revenue Market Share by Type (2021-2032)
5 Long-Acting Contraceptive Pills Market by Application
  1. 5.1 Long-Acting Contraceptive Pills Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Long-Acting Contraceptive Pills Sales by Application
  5. 5.2.1 Global Long-Acting Contraceptive Pills Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Long-Acting Contraceptive Pills Sales by Application (2021-2032)
  7. 5.2.3 Global Long-Acting Contraceptive Pills Sales Market Share by Application (2021-2032)
  8. 5.3 Global Long-Acting Contraceptive Pills Revenue by Application
  9. 5.3.1 Global Long-Acting Contraceptive Pills Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Long-Acting Contraceptive Pills Revenue by Application (2021-2032)
  11. 5.3.3 Global Long-Acting Contraceptive Pills Revenue Market Share by Application (2021-2032)
6 Global Long-Acting Contraceptive Pills Sales by Region
  1. 6.1 Global Long-Acting Contraceptive Pills Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Long-Acting Contraceptive Pills Sales by Region (2021-2032)
  3. 6.2.1 Global Long-Acting Contraceptive Pills Sales by Region (2021-2026)
  4. 6.2.2 Global Long-Acting Contraceptive Pills Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Long-Acting Contraceptive Pills Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Long-Acting Contraceptive Pills Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Long-Acting Contraceptive Pills Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Long-Acting Contraceptive Pills Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Long-Acting Contraceptive Pills Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Long-Acting Contraceptive Pills Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Long-Acting Contraceptive Pills Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Long-Acting Contraceptive Pills Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Long-Acting Contraceptive Pills Revenue by Region
  1. 7.1 Global Long-Acting Contraceptive Pills Revenue by Region
  2. 7.1.1 Global Long-Acting Contraceptive Pills Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Long-Acting Contraceptive Pills Revenue by Region (2021-2026)
  4. 7.1.3 Global Long-Acting Contraceptive Pills Revenue by Region (2027-2032)
  5. 7.1.4 Global Long-Acting Contraceptive Pills Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Long-Acting Contraceptive Pills Revenue (2021-2032)
  8. 7.2.2 North America Long-Acting Contraceptive Pills Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Long-Acting Contraceptive Pills Revenue (2021-2032)
  11. 7.3.2 Europe Long-Acting Contraceptive Pills Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Long-Acting Contraceptive Pills Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Long-Acting Contraceptive Pills Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Long-Acting Contraceptive Pills Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Long-Acting Contraceptive Pills Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Bayer
  2. 8.1.1 Bayer Company Information
  3. 8.1.2 Bayer Business Overview
  4. 8.1.3 Bayer Long-Acting Contraceptive Pills Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bayer Long-Acting Contraceptive Pills Product Portfolio
  6. 8.1.5 Bayer Recent Developments
  7. 8.2 Cipla
  8. 8.2.1 Cipla Company Information
  9. 8.2.2 Cipla Business Overview
  10. 8.2.3 Cipla Long-Acting Contraceptive Pills Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Cipla Long-Acting Contraceptive Pills Product Portfolio
  12. 8.2.5 Cipla Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Long-Acting Contraceptive Pills Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Long-Acting Contraceptive Pills Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Sun Pharma
  20. 8.4.1 Sun Pharma Company Information
  21. 8.4.2 Sun Pharma Business Overview
  22. 8.4.3 Sun Pharma Long-Acting Contraceptive Pills Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sun Pharma Long-Acting Contraceptive Pills Product Portfolio
  24. 8.4.5 Sun Pharma Recent Developments
  25. 8.5 Teva Pharmaceuticals
  26. 8.5.1 Teva Pharmaceuticals Company Information
  27. 8.5.2 Teva Pharmaceuticals Business Overview
  28. 8.5.3 Teva Pharmaceuticals Long-Acting Contraceptive Pills Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Teva Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolio
  30. 8.5.5 Teva Pharmaceuticals Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Long-Acting Contraceptive Pills Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Long-Acting Contraceptive Pills Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Mylan
  38. 8.7.1 Mylan Company Information
  39. 8.7.2 Mylan Business Overview
  40. 8.7.3 Mylan Long-Acting Contraceptive Pills Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Mylan Long-Acting Contraceptive Pills Product Portfolio
  42. 8.7.5 Mylan Recent Developments
  43. 8.8 Shanghai Pharmaceuticals
  44. 8.8.1 Shanghai Pharmaceuticals Company Information
  45. 8.8.2 Shanghai Pharmaceuticals Business Overview
  46. 8.8.3 Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolio
  48. 8.8.5 Shanghai Pharmaceuticals Recent Developments
  49. 8.9 Zhejiang Xianju Pharmaceutical
  50. 8.9.1 Zhejiang Xianju Pharmaceutical Company Information
  51. 8.9.2 Zhejiang Xianju Pharmaceutical Business Overview
  52. 8.9.3 Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Product Portfolio
  54. 8.9.5 Zhejiang Xianju Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Long-Acting Contraceptive Pills Value Chain Analysis
  2. 9.1.1 Long-Acting Contraceptive Pills Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Long-Acting Contraceptive Pills Production Mode & Process
  6. 9.2 Long-Acting Contraceptive Pills Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Long-Acting Contraceptive Pills Distributors
  9. 9.2.3 Long-Acting Contraceptive Pills Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst